| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/26/2009 | WO2008010101A8 Antagonist antibody against epha2 for the treatment of cancer |
| 03/26/2009 | WO2007008547A3 Sp35 antibodies and uses thereof |
| 03/26/2009 | WO2005117969A3 Solution phase biopanning method using engineered decoy proteins |
| 03/26/2009 | WO2005077046A3 A composition and method of treating mastitis |
| 03/26/2009 | WO2005074359A3 Watermelon varieties having altered sugar ratios |
| 03/26/2009 | WO2005060725A3 Nucleic acid amplification methods |
| 03/26/2009 | WO2005042702A3 Compositions of stabilized dna for coating microprojections |
| 03/26/2009 | WO2005017096A3 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 03/26/2009 | WO2004104161A3 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 03/26/2009 | WO2004096993A3 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 03/26/2009 | WO2004094651A3 Novel human polypeptides encoded by polynucleotides |
| 03/26/2009 | WO2004093804A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 03/26/2009 | WO2001066565A9 In vivo production of cyclic peptides |
| 03/26/2009 | US20090083886 Transgenic plants with increased glycine-betaine |
| 03/26/2009 | US20090083885 Plant produced vaccine for amebiasis |
| 03/26/2009 | US20090083883 D-Amino Acid Selection For Soybean |
| 03/26/2009 | US20090083882 Method for increasing the total oil content in oil plants |
| 03/26/2009 | US20090083881 Method for preventing mutation of pathogens exposed to transgenic plants |
| 03/26/2009 | US20090083880 Modified plant defensin |
| 03/26/2009 | US20090083878 Biological Containment System |
| 03/26/2009 | US20090083877 Transcription Factors, DNA and Methods for Introduction of Value-Added Seed Traits and Stress Tolerance |
| 03/26/2009 | US20090083876 Methods of affecting nitrogen assimilation in plants |
| 03/26/2009 | US20090083874 Production of proanthocyanidins to improve forage quality |
| 03/26/2009 | US20090083873 Sequence-specific inhibition of small rna function |
| 03/26/2009 | US20090083872 Production of Proteins in Eggs |
| 03/26/2009 | US20090083871 Targeting constructs for the functional disruption of avian immunoglobulin genes |
| 03/26/2009 | US20090083870 germ-line transformation systems; allow the physical deletion of transposon DNA following the transformation process; has ability to eliminate genomic positional effects and to comparatively study the biological effects of different transgenes |
| 03/26/2009 | US20090083865 Transgenic Mouse Lines Expressing Human Ace2 and Uses Thereof |
| 03/26/2009 | US20090083863 p300 transgenic animal |
| 03/26/2009 | US20090082600 Native homoethanol Pathway for ethanol production in E. coli |
| 03/26/2009 | US20090082556 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 03/26/2009 | US20090082555 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/26/2009 | US20090082550 Antibody compositions and methods |
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090082547 Compositions for enhancing transport of molecules into cells |
| 03/26/2009 | US20090082410 Constitutively translocating cell line |
| 03/26/2009 | US20090082307 Culturing Lac Z-Y+ E. coli cell on glycerol and glucose in presence of lactose as exogenous precursor and isopropyl beta -D-thiogalactoside as inducer under conditions inducing the internalization according to a mechanism of active transport of exogenous precursor by cell and production of lactose |
| 03/26/2009 | US20090082303 Drug for preventing and treating atherosclerosis |
| 03/26/2009 | US20090082300 Modulation of transthyretin expression |
| 03/26/2009 | US20090082299 Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells |
| 03/26/2009 | US20090082298 Methods for producing microRNAs |
| 03/26/2009 | US20090082297 Compositions and Methods for Regulating Gene Expression |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082294 Diagnosis, prevention and treatment of cancer |
| 03/26/2009 | US20090082293 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082290 Recombinant plasmid vector; nucleic acid sequence encoding a BMP-7 polypeptide operatively linked to a promoter; IGF-1 signal sequence, tPA signal sequence; signal peptide encoded by a nucleotide sequence; hemodynamic-based plasmid DNA gene delivery; delivery of naked plasmid; occlusion balloon catheter |
| 03/26/2009 | US20090082289 Adenoviral vectors having a protein IX deletion |
| 03/26/2009 | US20090082288 Methods and compositions for the treatment of uveitis |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082275 Ob protein compositions and methods |
| 03/26/2009 | US20090082274 Collections of repeat proteins comprising repeat modules |
| 03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090082264 123 Human Secreted Proteins |
| 03/26/2009 | US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 03/26/2009 | US20090082246 Amylase Variants |
| 03/26/2009 | US20090082225 Nucleic acid archiving |
| 03/26/2009 | US20090082223 Method and kit for the determination of cellular activation profiles |
| 03/26/2009 | US20090082217 Selection of nucleic acid-based sensor domains within nucleic acid switch platform |
| 03/26/2009 | US20090082215 Gene expression profiling from ffpe samples |
| 03/26/2009 | US20090082214 Conjugate probes and optical detection of analytes |
| 03/26/2009 | US20090082212 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
| 03/26/2009 | US20090081793 Method for improving acid and low pH tolerance in yeast |
| 03/26/2009 | US20090081792 Immune potentiating compositions of cancer cells |
| 03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
| 03/26/2009 | US20090081790 Polynucleotide for Target Gene |
| 03/26/2009 | US20090081789 Activation of nuclear factor kappa B |
| 03/26/2009 | US20090081788 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081779 Tumor suppressor gene, p28ing5 |
| 03/26/2009 | US20090081778 Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease |
| 03/26/2009 | US20090081777 Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugated |
| 03/26/2009 | US20090081776 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long |
| 03/26/2009 | US20090081764 Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay |
| 03/26/2009 | US20090081759 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long |
| 03/26/2009 | US20090081756 Nucleic acid-enzyme complex |
| 03/26/2009 | US20090081754 Gene of enzyme having activity to generate lachrymatory factor |
| 03/26/2009 | US20090081750 Transfection in magnetically driven continuous flow |
| 03/26/2009 | US20090081746 Biofuel production by recombinant microorganisms |
| 03/26/2009 | US20090081734 Arabinitol Dehydrogenases from Neurospora crassa |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081728 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences |
| 03/26/2009 | US20090081727 CD33-Like Protein |
| 03/26/2009 | US20090081725 Compositions of pamps and Listeria monocytogenes and methods of use |
| 03/26/2009 | US20090081724 identifying a subject predisposed to a disorder associated with ion channel dysfunction; epilepsy; isolated nucleic acid molecule encoding a mutant or variant ion channel subunit |
| 03/26/2009 | US20090081715 Engineered Light-Emitting Reporter Genes |
| 03/26/2009 | US20090081708 Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT) |
| 03/26/2009 | US20090081705 Novel peptides and compositions which modulate apoptosis |
| 03/26/2009 | US20090081692 Ceramide Kinase Loop |
| 03/26/2009 | US20090081691 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins |
| 03/26/2009 | US20090081682 High-throughput methods for identifying gene function using lentiviral vectors |
| 03/26/2009 | US20090081676 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 03/26/2009 | US20090081671 Method and apparatus for judging the presence or absence of cancer cell |
| 03/26/2009 | US20090081668 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 03/26/2009 | US20090081660 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2009 | US20090081655 Multiplex Real-time Quantitative PCR |
| 03/26/2009 | US20090081653 A nucleic acid regulating the expression of a gene responsive to insulin where the nucleic acid hybridizes under moderate stringency conditions to a hybridization probe; obesity; insulin-resistance syndrome; antidiabetic and -proliferative |